Steven C. Katz's Insider Trades & SAST Disclosures

Steven C. Katz's most recent trade in TriSalus Life Sciences Inc was a trade of 105,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TriSalus Life Sciences Inc
Katz Steven C. CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2024 105,000 105,000 - - Employee Stock Option (right to buy)
TriSalus Life Sciences Inc
Steven C. Katz CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2024 34,144 68,587 - 0 Common Stock
TriSalus Life Sciences Inc
Steven C. Katz Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 62,500 62,500 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades